Health
Second dose of Pfizer-BioNTech COVID-19 vaccine may not benefit previously infected individuals – News-Medical.Net
Researchers at the NYU Grossman School of Medicine have shown that a second dose of the Pfizer-BioNTech BNT162b2 vaccine may not offer any additional protection…
Researchers at the NYU Grossman School of Medicine have shown that a second dose of the Pfizer-BioNTech BNT162b2 vaccine may not offer any additional protection against coronavirus disease 2019 (COVID-19) over one dose among individuals previously infected with the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
In a study evaluating immune responses to the Pfizer-BioNTech vaccine, Ramin Herati and colleagues observed robust humoral (antibody) responses following two…
-
Noosa News14 hours agoShocking moment Bradley Donald Towle arrested after Bruce Hwy rampage and shooting on Sunshine coast
-
General15 hours agoNSW Police to provide update on Sydney woman’s kidnap from Bankstown home and killing
-
Noosa News21 hours agoMollie O’Callaghan admits to doubts, wins gold at Australian Open Swimming Championships
-
Noosa News14 hours agoQueensland woman charged with murdering partner with MND allegedly fed him ‘cocktail’ of medications